In the post-Brexit discussions on the UK's future medical devices regulatory instrument, two opposing views have emerged. One is that, given its sophisticated health care system, the UK will need its own processes of regulatory approval, and enough qualified staff to take care of those needs.
The other suggests the regulator should pursue merely a registration scheme for medtech products that it recognizes from international markets, and admit them to the UK market after a process...